Jazz Pharma slips as it lowers full-year guidance
Irish drug group reports 27% rise in sales but profit slips and supply disruptions remain
Irish drug group reports 27% rise in sales but profit slips and supply disruptions remain
Dublin-headquartered pharma company bringing new drugs to market this year
Jazz Pharmaceuticals affirms full year guidance despite challenges with two drugs
Company says increases attributed to higher sales of Xyrem and Defitelio in 2016
Nasdaq-listed specialty drug group expects to create 50 new jobs over three years
Dublin-based firm says it is on track to reach revenue predictions for 2015
Outlook for 2014 bullish after strong results for 2013, depsite fourth quarter undershooting analyst projections
Athlone project will create 50 high-skilled full-time jobs when completed by 2016.
Dublin pharma group continues expansion in specialty therapy sector
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices